Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Exercise/Conversion of 638 APVO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 638 | n/a |
| Aug 8, 2025 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 11,500 | n/a |
| Jul 21, 2025 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 3 | n/a |
| Mar 4, 2025 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 2 | n/a |
| Aug 9, 2024 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 213 | n/a |
| Jul 19, 2024 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 8,550 | n/a |
| Jun 3, 2024 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 42 | n/a |
| Mar 5, 2024 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 3,667 | n/a |
| Aug 10, 2023 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 9,375 | n/a |
| Jun 2, 2023 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 1,834 | n/a |